The Massey Cancer Center is a matrix center located at Virginia Commonwealth University. The mission of the Cancer Center is to provide comprehensive, cancer-focused basic, clinical, and population research, clinical services, outreach, and education to the State of Virginia and the nation. The major goals of the Cancer Center are 1) to facilitate high-quality basic, clinical, and population-based research focused on the cancer problem and 2) to promote interdisciplinary collaborations among the scientific programs and members of the Cancer Center in order to generate more effective interventions for cancer prevention and treatment. During the last project period, NCI funding for Cancer Center members increased from $9,352,802 (annual, total) to $15,777,576, and total peer-reviewed funding from $24,570,886 to $33,125,861. During this period we expanded our basic science research base, increased cancer focus in every research program, and increased clinical research activity. The Cancer Center's clinical facilities were renovated, and a new 80,000 g.s.ft. Cancer Center research laboratory building was completed. Major goals for the next grant period are to substantially broaden our clinical research activities, further increase the depth and scope of our basic research, and increase the focus in each of our research programs on the problems of health care disparities among racial, ethnic, and other underserved populations. Research activities of the Massey Cancer Center are carried out through five established research programs: Molecular Cancer Therapeutics, Cancer Cell Biology, Immune Mechanisms, Cancer Prevention and Control, and Radiation Biology and Oncology. The programs are structured to include both basic research and either clinical/translational or applied population research so as to facilitate transdisciplinary collaboration and rapid implementation of research findings in the treatment and prevention of cancer. In order to provide support for the predominantly peer-reviewed research base of the Massey Cancer Center programs, the Cancer Center supports several shared resources: Clinical Research;Biostatistics;Flow Cytometry;Molecular Biology;Nucleic Acid sequencing and synthesis;Structural Biology;Transgenic/Knockout Mouse;Cancer Research Informatics and Services;Tissue and Data Acquisition and Analysis;and Virus Vector production. This application requests continuation of the Cancer Center Support Grant to provide partial support for these shared resources as well as for senior leadership, program leadership, administration, protocol-specific research, program planning and evaluation, protocol review and monitoring, data and safety monitoring, and developmental funding, which are necessary to facilitate and stimulate interdisciplinary cancer research through the scientific programs of the Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016059-30
Application #
7826935
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ptak, Krzysztof
Project Start
1978-12-01
Project End
2012-04-30
Budget Start
2010-06-18
Budget End
2012-04-30
Support Year
30
Fiscal Year
2010
Total Cost
$924,535
Indirect Cost
Name
Virginia Commonwealth University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Ma, Yibao; Min, Hae-Ki; Oh, Unsong et al. (2017) The lignan manassantin is a potent and specific inhibitor of mitochondrial complex I and bioenergetic activity in mammals. J Biol Chem 292:20989-20997
van der Weyden, Louise; Arends, Mark J; Campbell, Andrew D et al. (2017) Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature 541:233-236
Schurman, Lesley D; Smith, Terry L; Morales, Anthony J et al. (2017) Investigation of left and right lateral fluid percussion injury in C57BL6/J mice: In vivo functional consequences. Neurosci Lett 653:31-38
Newton, Jason; Hait, Nitai C; Maceyka, Michael et al. (2017) FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts. FASEB J 31:1719-1730
Manzanares, Miguel Á; Usui, Akihiro; Campbell, Deanna J et al. (2017) Transforming Growth Factors ? and ? Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model. Am J Pathol 187:1068-1092
Arsenovic, Paul T; Mayer, Carl R; Conway, Daniel E (2017) SensorFRET: A Standardless Approach to Measuring Pixel-based Spectral Bleed-through and FRET Efficiency using Spectral Imaging. Sci Rep 7:15609
Lownik, Joseph C; Luker, Andrea J; Damle, Sheela R et al. (2017) ADAM10-Mediated ICOS Ligand Shedding on B Cells Is Necessary for Proper T Cell ICOS Regulation and T Follicular Helper Responses. J Immunol 199:2305-2315
Karki, Kishor; Saraiya, Siddharth; Hugo, Geoffrey D et al. (2017) Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning. Int J Radiat Oncol Biol Phys 99:80-89
Meier, Jeremy A; Hyun, Moonjung; Cantwell, Marc et al. (2017) Stress-induced dynamic regulation of mitochondrial STAT3 and its association with cyclophilin D reduce mitochondrial ROS production. Sci Signal 10:
Benson, Zachary; Manjili, Saeed H; Habibi, Mehran et al. (2017) Conditioning neoadjuvant therapies for improved immunotherapy of cancer. Biochem Pharmacol 145:12-17

Showing the most recent 10 out of 499 publications